The renin–angiotensin–aldosterone system (RAAS) plays an important role in the pathogenesis
of a variety of clinical conditions, including atherosclerosis, hypertension, left ventricular …

… The renin–angiotensin system (RAS) plays key roles throughout the … and blockade of this
system—either through angiotensin-converting enzyme (ACE) inhibition or through angiotensin …

… Although there has been an abundance of observational data and opinion‐based narrative
reviews on renin angiotensin system blockade in kidney transplantation, our analysis is …

… Blockade of RAAS has been shown to be beneficial in patients with … RAAS blockade with
combination of two commonly used RAAS blockers [ACE inhibitors (ACEIs) and angiotensin …

… As the newest homologue of angiotensin-converting enzyme (ACE), ACE2 has … renin-angiotensin
system (RAS) since the enzyme has a substrate preference for hydrolyzing angiotensin …

The renin-angiotensin-aldosterone system plays a key role in the regulation of fluid and
electrolyte balance. Angiotensin-converting enzyme inhibitors inhibit angiotensin-converting …

… The aliskiren and valsartan to reduce NT-proBNP via renin–angiotensin–aldosterone system
blockade (AVANT-GARDE) study investigated whether aliskiren, alone or in combination …

… single-site blocker” of the renin angiotensin system designates either an ACE inhibitor or an
… blockade” of the renin angiotensin system designates the combination of an ACE inhibitor …

… of renin-angiotensin system blockade … and angiotensin receptor blockers (ARBs) are
perceived to be relatively contraindicated in AS. However, inhibitors of the renin-angiotensin system …

… in renin-angiotensin system (RAS… blockade. The renal and peripheral hemodynamic
responses to incremental dosages of an angiotensin receptor blocker and the degree of angiotensin …